Investor

Asabys Partners

asabys.com ↗ ·Barcelona ·Early stage ·Actively investing

Asabys Partners is a Barcelona-based venture capital firm investing exclusively in human healthcare, spanning biopharma, medtech, diagnostics, digital health and AI-driven health solutions. It backs early- to growth-stage companies in Spain and internationally, taking a hands-on, board-level role in portfolio companies. The firm manages roughly €280M across two funds (an €80M fund I and a €200M fund II closed in 2023) and has invested in around 29 companies including Splice Bio, Ona Therapeutics, Inbrain Neuroelectronics and Peptomyc.

Portfolio
17
Team
16
AUM
~€300M
Rounds
25
Cheque
€3–10M
SectorsBiotech, Medtech, Digital health, Diagnostics, Health-tech VC MapSeries B

Profile updated 18 Jul 2026

Team

Clara Campàs
Co-founder & Managing Partner
Emilio Erazo-Fischer
Operating Partner
Guillem Masferrer
Partner
Jose María Fernández
Partner
Josep Ll. Sanfeliu
Co-founder & Managing Partner
Montse Vendrell
Partner
Sylvain Sachot
Partner
Anna Bellmunt
Senior Associate
Antonio Limatola
Senior Associate
Beatriz Gandarias
Senior Associate
—
Isabel Jiménez
Principal
Maite Malet
Principal
Laia Romero
Executive Assistant
Mònica Sabé
Executive Assistant - Office Manager
—
Núria Aloy
CFO
Pilar Almajano
Financial Controller

Portfolio companies 17

Funding rounds 25

Anaconda Biomed · Series C · $56M
Anaconda Biomed was founded in Barcelona and also has an office in Marin, California. It raised $56M to complete the ATHENA pivotal IDE stud…
2026-09-23
iPremom · Seed · €15M
iPremom, co-founded by Prof. Carlos Simón and Dr. Tamara Garrido, raised a €15M Seed round led by Amadeus Capital Partners with Asabys Partn…
2026-09-02
Ona Therapeutics · Series B · €74.2M
IRB Barcelona spin-out closed an oversubscribed €74.2M Series B co-led by Columbus and Mérieux to take its first-in-class antibody-drug conj…
2026-06-04
Qida · Series B · €37M
Barcelona-based home eldercare platform Qida raised €37M in what was described as the largest social impact investment round closed in Spain…
2025-11-04
SpliceBio · Series B · $135M
SpliceBio closed a $135M (about €118M) Series B co-led by new investors EQT Life Sciences and Sanofi Ventures, with Roche Venture Fund joini…
2025-06-11
deepull · Series C · €50M
Barcelona-based medtech deepull closed an oversubscribed €50 million Series C co-led by Columbus Venture Partners, Panakès Partners and Méri…
2025-04-29
Quibim · Series A · $50M
Quibim raised a $50M Series A co-led by Asabys Partners and Buenavista Equity Partners, with Amadeus Capital Partners, Apex Ventures, Partec…
2025-01-28
Anaconda Biomed · Other · €3.6M
CDTI Innovación, through its Innvierte programme, agreed to co-invest €3.6M in neurovascular medtech Anaconda Biomed alongside existing shar…
2025-01-10
INBRAIN Neuroelectronics · Series B · $50M
Barcelona-based INBRAIN Neuroelectronics, an ICN2/CSIC spin-off developing graphene-based brain-computer interfaces for neurological conditi…
2024-10-29
Allox · Seed
CDTI Innovación announced an equity investment in Allox (Allostery Exploration Technologies) alongside Asabys Partners; the amount was not d…
2024-09-12
Medlumics · Other
CDTI Innovación announced a €926,000 commitment to Medlumics alongside Asabys Partners (via Sabadell Asabys Health Innovation Investments an…
2024-07-29
MedLumics · Other
CDTI Innovación, through its Innvierte programme, announced a co-investment agreement with Asabys Partners (via Sabadell Asabys Health Innov…
2024-02-13
ALLOX · Pre-seed
ALLOX, a techbio spin-off of the Centre for Genomic Regulation that designs drugs targeting allosteric sites on 'undruggable' proteins, anno…
2023-11-30
Orikine Bio · Seed · €5.5M
Orikine Bio, a synthetic-biology spin-off of Barcelona's Centre for Genomic Regulation developing engineered cytokines ('Foldikines') for au…
2023-07-18
Nuage Therapeutics · Seed · €12M
Nuage Therapeutics, an IRB Barcelona and ICREA spin-off based at the Barcelona Science Park, raised €12 million in seed financing to advance…
2023-06-20
Nuage Therapeutics · Seed
CDTI Innovación disclosed a €450,000 commitment through Innvierte to Nuage Therapeutics, an IRB Barcelona and ICREA spin-out developing drug…
2023-03-14
DeepUll · Series B · €17M
Barcelona Science Park-based DeepUll, which develops culture-free molecular diagnostics for early sepsis detection, announced that Sabadell …
2023-03-01
Amelia Virtual Care · Series B · €7M
Amelia Virtual Care (formerly Psious), the Barcelona-headquartered virtual-reality mental health platform used by over 2,000 therapists, ann…
2022-06-28
SpliceBio · Series A · €50M
SpliceBio raised an oversubscribed €50M Series A for its protein-splicing platform, which uses engineered inteins from Princeton's Muir Lab …
2022-02-16
Nuage Therapeutics · Seed
Nuage Therapeutics is a drug-discovery spin-off of IRB Barcelona and ICREA. It launched with undisclosed early financing from Sabadell Asaby…
2021-09-27
MedLumics · Series E · €18M
MedLumics, which is developing the AblaView ablation catheter system for atrial fibrillation, closed an enlarged €18M ($21.7M) round when Ku…
2021-02-10
Koa Health · Series A · €30M
Koa Health, a digital mental health company spun out of Telefónica, closed an oversubscribed €30M ($36M) Series A. Wellington Partners Life …
2021-02-09
Medlumics · Series E · €14M
Medlumics makes medical devices and is developing the AblaView cardiac ablation system, which uses photonics and optical imaging. It closed …
2020-10-08
Origo Biopharma · Seed · €2.3M
Origo Biopharma closed a €2.3M Series Seed round led by Asabys Partners through its Sabadell Asabys Health Innovation Investments fund, with…
2020-07-07
Origo Biopharma · Seed · €2.3M
Origo Biopharma closed a €2.3M Series Seed round led by Asabys Partners through its Sabadell Asabys Health Innovation Investments fund, with…
2020-07-07

News & media 10

Start typing to search across everything.
↑↓ navigate↵ openesc close